Robust M&A Activity Provides Tailwind to Biotech Sector
April 18, 2024
Nierengarten, David
Innovative New Cell and Gene Therapies Show Transformative Benefits
August 18, 2022
Prasad, Raju
Biotechs Hit Bottom and Bounce Back — Twice
August 18, 2022
Nierengarten, David
Seeing a Bifurcation of Therapeutic Focus in the Oncology Space
September 30, 2020
Nierengarten, David